Roundup: Cardiac Insight to Enter APAC Market, China’s Dingdang Health Raises $ 220 Million and More Summaries

Roundup: Cardiac Insight to Enter APAC Market, China’s Dingdang Health Raises $ 220 Million and More Summaries

Cardiac Insight’s ECG patch and analysis software system make up its seven-day ambulatory ECG system that provides rapid, in-clinic automated cardiac analysis and reporting. It is a standalone solution that does not require internet access, cloud computing solutions or third-party outsourcing. “Our international distribution partnership with i.SigNal by Dreamtech is a key collaboration for Cardiac Insight, combining our first-in-class ECG technology with i.SigNal’s strategic healthcare market focus that will accelerate [the] adoption of the Cardea SOLO System on a global scale,” Cardiac Insight CEO Brad Harlow said in a statement.

“Cardiac Insight’s market-disrupting ECG patch technology delivers compelling value to Korea and Asia-Pacific markets by providing increased productivity to health care systems. It will help physicians improve the detection, diagnosis and treatment of serious cardiac arrhythmias such as atrial fibrillation, that, left untreated, can lead to disabling stroke, heart failure and death,” said Dreamtech CEO Min Kim. In a statement, Yang Wenglong, its founder and chairman, said the company will use the proceeds to offer more services, including medical care, medicine delivery and health insurance.

Chinese digital healthcare platform Dingdang Kuaiyao (Dingdang Health) has secured $220 million in the latest financing round led by TPG Capital Asia, OrbiMed and Redview Capital. “Riding on the new trend of online medical care and medication services amid COVID-19, we aim at providing all-encompassing online services catering to various needs including consultation, drug purchase, chronic disease management and psychological consultation through product upgrades and technological innovation,” Yang added.

Dingdang Health to expand online care services after raising $220M Dreamtech’s i.SigNal secured a medical device license for Cardea SOLO from the Korean Ministry of Food and Drug Safety late last year. It will continue obtaining regulatory approvals and conduct distribution activities in other Asia-Pacific markets.

Launched in 2015, Dingdang Health sells medications from manufacturers and physical pharmacies and offers telemedicine services. It also runs its own offline pharmacies in over 10 major cities in China, such as Beijing and Shanghai. Last year, the company netted 1 billion yuan or around $150 million in a B+ funding round joined by Softbank China, CMB International and Sinopharm-CICC Capital.

Indonesian digital health startup Alodokter has raised an undisclosed sum from Telkom Group’s MDI Ventures and Samsung Ventures. In a press statement, the company said it will use the proceeds to “continually expand and digitise the healthcare ecosystem as well as develop new products for Alodokter’s platform”. “The investment from MDI Ventures and Samsung Ventures will be directed to further improve Alodokter’s ecosystem. Key focus areas going forward include technology innovation, increasing the talent pool and adding new features and functionalities. The expansion we carried out is always focused on providing fast, accurate, and reliable consumer experience on the Alodokter platform,” Alodokter Founder and CEO Nathanael Faibis said. Digital health startup Alodokter scores fresh funds to develop new products

News Highlights Health

  • Roundup: Cardiac Insight to Enter APAC Market, China’s Dingdang Health Raises $ 220 Million and More Summaries
  • Check all news and articles from the Health news information updates.
Disclaimer: If you need to update/edit/remove this news or article then please contact our support team.
For Latest Updates Follow us on Google News
Bollyinside - US Local News & Breaking News Stories
Compare items
  • Total (0)